Medical Marijuana: A Challenge to Traditional Pain Relief?
Published in Pharmaceutical Executive November 2017
Medical use of marijuana for a broad range of conditions is expanding rapidly in the US, as legalization gathers pace and investors flock to a booming market. A January 2017 report for the National Academies of Sciences, Engineering and Medicine (NASEM) found substantial or conclusive evidence of marijuana’s therapeutic benefit in chronic pain, multiple sclerosis and chemotherapy-induced nausea and vomiting. Other, more tentative US state-approved indications include diabetes, glaucoma, epilepsy, migraine, post-traumatic stress disorder, hepatitis C, Crohn’s disease, Parkinson’s diseaseand Tourette syndrome.
Living with NASH: An Unexpected Diagnosis
Published in eyeforpharma November 2017 by Mariel Metcalfe
With no current licensed treatments and more than 20 compounds in phase II and III, the liver disease non-alcoholic steatohepatitis (NASH) represents a huge opportunity for pharma companies – if they understand patient needs. As our waistlines thicken and our activity levels decrease, another chronic illness threatens to disturb our comfortable lifestyles. And, because it’s relatively unknown, diagnosis comes as a shock to patients, who usually associate liver disease with heavy consumption of alcohol.
Live from Singapore: Going for growth - Maximising your return on insights in emerging markets
Thursday 30th November 2017 16:00 SGT/ 16:00 CST / 17:00 JST
Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Join Emerging Markets experts Nicole Bender Moreira and Colin Tan for our forthcoming webinar ‘Going for growth’ live from Singapore in which they will provide you with the critical success factors to ensure actionable primary research in emerging markets.
20 questions: Round 7
As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What project or event has been most memorable to you at RP?"
PMRC EU, Düsseldorf 2017
We were delighted to exhibit and present a paper at the Pharmaceutical Market Research Conference in Düsseldorf, Germany
Director, Anne Cunningham, and Associate Director, Nicky Barclay-Prout, represented us at the conference and presented the paper ‘Patient Centricity: Keeping Patients at the Forefront’.